covid-19 vaccine

The Food and Drug Administration is planning to authorize a new generation of COVID-19 boosters this week that for the first time will target the omicron variant.

Adults who haven't gotten any COVID-19 shots should consider the new option, the agency said Tuesday. The spike protein vaccine is more typical than the mRNA types being broadly used against COVID.

Pediatric infectious disease specialist Dr. Jana Shaw discusses the COVID-19 vaccine for children 6 months to 5 years of age. Psychiatrist Sunny Aslam gives advice for placing sports bets without developing a gambling addiction. Upstate's Clark Burn Center program manager Tamara Roberts provides fireworks and other summer safety tips. And chief of geriatrics, Dr. Sharon Brangman explains how, and when, to take the car keys from an aging parent.

A pediatric infectious disease specialist from Upstate Golisano Children’s Hospital says vaccines for the 6-month to 5-year-old age group have gone through extensive clinical trials.

NPR talks to Claire Hannan, who has helped navigate vaccine rollouts in all 50 states, about some of the challenges involved in quickly getting shots out to millions of young kids.

The vaccinations for children as young as 6 months old could start next week. But first, the Centers for Disease Control and Prevention must sign off.

The "bivalent" vaccine — meaning it targets two different antigens — is Moderna's leading candidate for an effective booster this fall. If the data pan out, it could lead to a yearly booster.

The Novavax vaccine appears to be about 90% effective at preventing mild, moderate and severe COVID-19, Food and Drug Administration scientists say in an analysis of the company's data.

COVID-19 vaccinations for children younger than 5 could start right after the Juneteenth holiday.

Pfizer plans to submit new data to the Food and Drug Administration this week, bringing families with young children one step closer to a long-awaited vaccine.